Find a Tender
complete
Official procurement procedure
For the supply of Pulmicort Turbohaler 400
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health and Social Care: "For the supply of Pulmicort Turbohaler 400". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Department of Health and Social Care | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Department of Health and Social Care
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Department of Health and Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
11.8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 451 active published awards; 397 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDepartment of Health and Social Care | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published25 Apr 2022, 10:47 BST | Last source update25 Apr 2022, 10:47 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-032fe5 | ||
What is being bought
The Department of Health and Social Care (DHSC) has awarded Contract for the Supply of Pulmicort Turbohaler 400mg.
What changed
From the official release history
- Status changed to complete
25 Apr 2022, 10:47 BST - Official notice release published
25 Apr 2022, 10:47 BST - Buyer information updated
25 Apr 2022, 10:47 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe Department of Health and Social Care conducted a Direct Award under the Regulation 32(2)(b)(iii) of the Public Contracts Regulations 2015 (as amended) for the supply of Pulmicort Turbohaler 400 mg. The contract period expires on 31 March 2022.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
25 Apr 2022, 10:47 BST - Award active
Not published · Not published - Contract active
Signed 23 Feb 2022, 00:00 GMT · £1,083,200
Commercial outcome and competition
Awards ASTRAZENECA UK LIMITED Not published · Not published · active |
Contracts Contract £1,083,200 · signed 23 Feb 2022, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
Department of Health and Social Care
Contracting authority GB-FTS-43Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe Authority used the negotiated procedure without prior publication under Regulation 32(2)(b)(iii) – to protect exclusive rights to purchase a quantity of Pulmicort Turbohalers 400mg. The Supplier has exclusive rights to manufacture and distribute the Pulmicort Turbohalers 400mg. This product has a unique mechanism capable of delivering a precise dose to patients and has a proven clinical effect on the treatment of individuals with COVID-19 and other illnesses. This unique delivery system means there are no suitable or reasonable alternatives to this product. |